{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Sean Gross"}, {"accession": "MS:1000589", "name": "contact email", "value": "grossse@ohsu.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "OHSU"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Peter Rotwein"}, {"accession": "MS:1000589", "name": "contact email", "value": "peter.rotwein@ttuhsc.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of Biomedical Sciences Paul L. Foster School of Medicine Texas Tech Health Sciences Center 5001 El Paso Drive El Paso, Texas 79905"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_11%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_14%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_17%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_20%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_23%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_26%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_30%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_50%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_8%_ACN_20140923_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_90%_ACN_20140922_OT.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_inject_20140922_OT.raw"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413/ROT1582_second-mudpit_20140921.msf"}], "description": "The p38 MAP kinases play critical roles in skeletal muscle biology, but the specific processes that they regulate remain poorly defined.  Here we find that activity of p38\u03b1/\u03b2 is important not only for early phases of myoblast differentiation, but also in later stages of myocyte fusion and myofibrillogenesis.  By treating C2 myoblasts with the pro-myogenic growth factor, IGF-I, we were able to overcome the early block in differentiation imposed by co-incubation with the p38 chemical inhibitor, SB202190.  Yet, IGF-I could not overcome the later impairment of muscle cell fusion, as marked by the nearly complete absence of multinucleated myofibers.  Removal of SB202190 from the medium of differentiating myoblasts showed that the fusion block was reversible, as multinucleated myofibers were detected several hours later, and reached ~90% of the culture within 30 hours.  Analysis by quantitative mass spectroscopy of proteins that changed in abundance following removal of the inhibitor revealed a cohort of up-regulated muscle-enriched molecules that may be important for both myofibrillogenesis and fusion.  We have thus developed a model system that allows separation of myoblast differentiation from muscle cell fusion, which should be useful in identifying specific steps regulated by p38 MAP kinase-mediated signaling in myogenesis.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD002413"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD002413"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD002413"}], "instruments": [{"accession": "MS:1002417", "name": "Orbitrap Fusion ETD"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "mouse, myoblast, fusion, differentiation"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biological"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "26246429"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Gardner S, Gross SM, David LL, Klimek JE, Rotwein P. Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190. Am J Physiol Cell Physiol. 2015 309(7):C491-500"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus (Mouse)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}], "title": "Mouse myoblast fusion"}